Theoretical and transplantation studies have indicated that renal dysfunction underlies the development and maintenance of hypertension; however, the factors that """"""""reset the kidney in hypertension"""""""" are unknown. This proposal focuses on the hypothesis that an elevation in renal medullary vascular resistance is responsible for the abnormal sodium reabsorption in hypertension. We will evaluate the contribution of an elevation in renal sympathetic tone, a deficiency in the kallikrein-kinin system, and/or alterations in renal arachidonic acid metabolism to the resetting of tubular and vascular function. The effects of renal denervation, pharmacologic manipulation of the kallikrein-kinin system (using kininase inhibitors and a kinin antagonist) and alterations in renal eicosanoid production (using inhibitors of cyclooxgenase, thromboxanesynthetase and cytochrome P450 metabolism of arachidonic acid) on the pressure-natriuretic response, renal cortical and medullary hemodynamics and sodium reabsorption in superficial and deep nephrons will be compared in normotensive and hypertensive rats. Renal hemodynamics will be studied using laser- Doppler spectoroscopy and videomicroscopy. Tubular function will be evaluated using micropuncture. The urinary excretion of eicosanoids and the renal metabolism of arachidonic acid will be studied using radiochemical and radioimmunoassay techniques. Kallikrein and kinin excretion will be determined using radioimmunoassay. These studies will provide important new information on the role of the renal nerves, the kallikrein-kinin and renal eicosanoid systems in the regulation of vasa recta hemodynamics, renal interstitial pressure and tubular function, and the participation of these systems in the development of hypertension.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL036279-05
Application #
3351161
Study Section
Cardiovascular and Renal Study Section (CVB)
Project Start
1986-07-01
Project End
1994-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
5
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Medical College of Wisconsin
Department
Type
Schools of Medicine
DUNS #
073134603
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Zhang, Chao; Booz, George W; Yu, Qing et al. (2018) Conflicting roles of 20-HETE in hypertension and renal end organ damage. Eur J Pharmacol 833:190-200
Shekhar, Shashank; Cunningham, Mark W; Pabbidi, Mallikarjuna R et al. (2018) Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches. Eur J Pharmacol 833:531-544
Roman, Richard J; Fan, Fan (2018) 20-HETE: Hypertension and Beyond. Hypertension 72:12-18
Shekhar, Shashank; Liu, Ruen; Travis, Olivia K et al. (2017) Cerebral Autoregulation in Hypertension and Ischemic Stroke: A Mini Review. J Pharm Sci Exp Pharmacol 2017:21-27
Fan, Fan; Roman, Richard J (2017) GPR75 Identified as the First 20-HETE Receptor: A Chemokine Receptor Adopted by a New Family. Circ Res 120:1696-1698
Fan, Fan; Roman, Richard J (2017) Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology. J Am Soc Nephrol 28:2845-2855
Shekhar, Shashank; Travis, Olivia K; He, Xiaochen et al. (2017) Menopause and Ischemic Stroke: A Brief Review. MOJ Toxicol 3:
Zhang, Hui; Falck, John R; Roman, Richard J et al. (2017) Upregulation of 20-HETE Synthetic Cytochrome P450 Isoforms by Oxygen-Glucose Deprivation in Cortical Neurons. Cell Mol Neurobiol 37:1279-1286
Fan, Fan; Ge, Ying; Lv, Wenshan et al. (2016) Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology. Front Biosci (Landmark Ed) 21:1427-63
Miller, Bradley; Palygin, Oleg; Rufanova, Victoriya A et al. (2016) p66Shc regulates renal vascular tone in hypertension-induced nephropathy. J Clin Invest 126:2533-46

Showing the most recent 10 out of 170 publications